Home › Funds › CONWAY CAPITAL MANAGEMENT, INC. › BSX

CONWAY CAPITAL MANAGEMENT, INC. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

CONWAY CAPITAL MANAGEMENT, INC. reported holding 26,600 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.49% of its reported portfolio and ranking #24 among its reported holdings. CONWAY CAPITAL MANAGEMENT, INC. has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.60K sh
Reported value held$1.16M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CONWAY CAPITAL MANAGEMENT, INC.'s BSX position evolved

CONWAY CAPITAL MANAGEMENT, INC. first disclosed a stake in BSX in Q3 2023 at 34,015 shares (US$1.8M). The position peaked in Q2 2025 at 29,645 shares, worth US$3.2M. Across 13 filings, CONWAY CAPITAL MANAGEMENT, INC. increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 26,600 shares valued at US$1.2M — a reduction of -2,150 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.02K $1.80M New
Q4 2023 31.93K $1.85M Reduce
Q1 2024 31.93K $2.19M Hold
Q2 2024 31.93K $2.46M Hold
Q3 2024 31.93K $2.68M Hold
Q4 2024 31.93K $2.85M Hold
Q1 2025 31.37K $3.16M Reduce
Q2 2025 29.64K $3.18M Reduce
Q3 2025 29.64K $2.89M Hold
Q4 2025 29.39K $2.80M Reduce
Q1 2026 28.90K $1.81M Reduce
Q2 2026 28.75K $1.23M Reduce
Q3 2026 26.60K $1.16M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has CONWAY CAPITAL MANAGEMENT, INC. held BSX?

CONWAY CAPITAL MANAGEMENT, INC. has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONWAY CAPITAL MANAGEMENT, INC.'s current position in BSX?

As of Q3 2026, CONWAY CAPITAL MANAGEMENT, INC. holds 26.60K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $1.16M, representing 0.49% of its reported portfolio and ranking #24.

Has CONWAY CAPITAL MANAGEMENT, INC. been buying or selling BSX?

In the latest 13F filing (Q3 2026), CONWAY CAPITAL MANAGEMENT, INC. reduced its position in BSX. The position peaked in Q2 2025 at 29.64K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.